Leland Gershell
2016 - Tonix Pharmaceuticals Holding
In 2016, Leland Gershell earned a total compensation of $425.1K as Former Chief Financial Officer at Tonix Pharmaceuticals Holding, a 27% decrease compared to previous year.
Compensation breakdown
Salary | $33,056 |
---|---|
Other | $392,000 |
Total | $425,056 |
Gershell received $392K in other compensation, accounting for 92% of the total pay in 2016.
Gershell also received $33.1K in salary.
Rankings
In 2016, Leland Gershell's compensation ranked 11,717th out of 14,075 executives tracked by ExecPay. In other words, Gershell earned more than 16.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,717 out of 14,075 | 17th |
Division Manufacturing | 4,580 out of 5,489 | 17th |
Major group Chemicals And Allied Products | 1,635 out of 1,895 | 14th |
Industry group Drugs | 1,324 out of 1,538 | 14th |
Industry Pharmaceutical Preparations | 1,025 out of 1,176 | 13th |
Source: SEC filing on May 2, 2017.
Gershell's colleagues
We found three more compensation records of executives who worked with Leland Gershell at Tonix Pharmaceuticals Holding in 2016.